[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"notifications-list":3,"$f1a9ttj8kamkfl":5},{"data":4},[],{"data":6,"error":11},{"id":7,"documentId":8,"slug":9,"name":10,"medical_code":11,"short_description":12,"alternate_name":11,"disambiguating_description":11,"citations":13,"drugs":19,"specialties":24,"cover":11},974,"sph9jeovatmwm9xn48997o8z","antidotes","Antidotes",null,"ALL OTHER THERAPEUTIC PRODUCTS > ALL OTHER THERAPEUTIC PRODUCTS > Antidotes.",[14],{"source":15,"licence":16,"source_url":17,"retrieved_at":18},"UK VMD Summary of Product Characteristics, section 4.1","EMA and VMD register content, Crown\u002FEU public register","https:\u002F\u002Fwww.vmd.defra.gov.uk\u002FProductInformationDatabase\u002Ffiles\u002FSPC_Documents\u002FSPC_261705.PDF","2026-09-20",[20],{"id":21,"documentId":22,"slug":23,"name":23,"active_ingredient":11,"dosage_form":11,"administration_route":11},1858,"h15wrolb4xn8rxs1omappa0i","diprenorphine",[]]